CME Group heads into its third-quarter report with a question that a single month of data cannot answer. Last quarter, growth slowed to a crawl after a record first quarter, and management spent much of its call defending the futures model against perpetual-contract upstarts and a dispute with the CFTC. It did offer one strong counterpoint: July volume was running about 18% ahead of last year. The October 21 release, due before the open, will show whether that start carried through the full quarter or faded.
The Street expects earnings of $2.96 a share on revenue of $1.70 billion, gains of roughly 10.5% and 10.6% from the year-ago $2.68 and $1.54 billion. That would be a clear reacceleration from the second quarter's 1% growth. Much of it comes from an easy comparison, though. Sequentially, consensus is essentially flat on revenue and a few cents lighter on earnings than the $2.99 CME just posted. Management did not issue a fresh numerical outlook, but it broadly reaffirmed its plans without cuts, so analysts are effectively modeling a steady quarter rather than a breakout one.
That makes volume and pricing the key swing factors. Second-quarter average daily volume of 29.8 million contracts fell well short of the first quarter's record 36.2 million, and the adjusted operating margin slipped to 69.5% from 72.8%. Exchange costs are largely fixed, so incremental contracts drop heavily to the bottom line. If July's pace held up even partially, and equity index activity, which ran 40% to 50% higher in July, stayed elevated, the margin should rebound toward the low 70s. Revenue per contract is the other lever. It rose to 67.8 cents from 65.2 cents last quarter, and holding that gain while volume grows would point to upside against a consensus that assumes little operating leverage.
Market data remains the steadiest part of the story. It hit a record $238 million last quarter, up 20%, extending a run of 33 straight quarters of year-over-year growth and a clean sequential climb. Another step up would reinforce the recurring-revenue case that helps CME trade at a premium to purely transactional businesses. A stall would be the first crack in that line. Open interest also deserves attention. Its growth cooled to 8% from 11% in the first quarter, and renewed expansion would suggest positions are building rather than just churning.
The newer catalysts should start producing early evidence. Single stock futures launched with more than 35 retail partners, and investors will want early adoption figures alongside updates on 24/7 gold and crypto trading. They will also look for progress on compute futures with Silicon Data and the Treasury Link rollout planned for the fourth quarter. The regulatory overhang is just as important. The CFTC halted the 24/7 crude contract on the eve of launch, the agency's response in the related litigation was due at the end of August, and any clarity on either front will shape how the market views the perpetual-futures threat.
The stock suggests investors have already regained some confidence. Shares are up 12% since the last report, about 7.8 points ahead of the S&P 500, and sentiment has turned modestly less bearish than a quarter ago. At $277, however, the stock sits just below its 200-day moving average and about 4% under its post-earnings high of $289.90, so it has not broken out. The central issue is whether the second-quarter slowdown was a one-off caused by tough comparisons or an early sign of a maturing franchise under competitive pressure. Strong volume, firm pricing and a margin rebound would support the first view, while a flat quarter would keep the defensive narrative in charge.